Skip to content
MedsAcross

Medicine

Armodafinil 250 mg tablet

Armodafinil · Oral
Available on requestPrescription onlyUS FDAControlled, schedule CIVGeneric name

Armodafinil 250 mg tablet is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Armodafinil
Brand
Sold under the generic name
Strength
250 mg
Dosage form
Tablet
Route
Oral
Packs
500 tablets, 30 tablets, 60 tablets and 11 more
Manufacturers
Aurobindo PharmaIndiaNatco PharmaIndiaBryant Ranch PrepackDirect_RxMylan PharmaceuticalsQuality Care ProductsSandozTeva Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CIV
ATC code
N06BA13 Armodafinil
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 June 2016
Identifiers
RxCUI 724861, 724859, 724863 +1DailyMed set ID b1ba1cdd-cf57-7a8c-e053-2a95a90a2c19, 23da56b8-7552-4362-a1ab-e794c131194c, de2f0921-e791-426c-9192-2b7162e2158c +5NDC 72189-133, 65862-807, 69339-180 +6Application ANDA206069, ANDA202768, ANDA200043 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
500 tablet in 1 bottle65862-807-05Aurobindo PharmaIndia6 March 2018
30 tablet in 1 bottle65862-807-30Aurobindo PharmaIndia6 March 2018
60 tablet in 1 bottle65862-807-60Aurobindo PharmaIndia6 March 2018
30 tablet in 1 bottle69339-180-03Natco PharmaIndia23 March 2023
500 tablet in 1 bottle69339-180-05Natco PharmaIndia23 March 2023
30 tablet in 1 bottle, plastic0378-3433-93Mylan Pharmaceuticals1 June 2016
30 tablet in 1 bottle0781-8053-31Sandoz1 December 2016
30 tablet in 1 bottle0093-3094-56Teva Pharmaceuticals29 November 2016
30 tablet in 1 bottle72189-133-30direct rx15 October 2020
30 tablet in 1 bottle72189-261-30direct rx13 September 2021
30 tablet in 1 bottle71335-1308-1Bryant Ranch Prepack23 August 2019
28 tablet in 1 bottle71335-1308-2Bryant Ranch Prepack23 August 2019
90 tablet in 1 bottle71335-1308-3Bryant Ranch Prepack23 August 2019
30 tablet in 1 bottle55700-510-30Quality Care Products29 November 2016

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 15 June 2007Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Armodafinil 250 mg tablet.

Compare 1

Other strengths and forms of Armodafinil

Clinical summary

Armodafinil is a prescription medicine indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD). It is available as tablets for oral use. MedsAcross supplies Armodafinil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Armodafinil

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Armodafinil 250 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.